Escolar Documentos
Profissional Documentos
Cultura Documentos
Details of the many charities, governmental bodies, and scientific funding organizations that supported the epidemiologic study, including phenotyping, DNA
collection, and genotyping for the British 1958 Birth Cohort (B58C), the European Community Respiratory Health Survey (ECRHS2), the Northern Finland
Birth Cohort of 1966 (NFBC1966), and the Swiss Study on Air Pollution and
Lung Disease in Adults (SAPALDIA), can be found in this articles Online Repository at www.jacionline.org. A. R. has received research support from the European Commission (through project GABRIEL, contract no. 018996 under the
Integrated Program LSH-2004-1.2.5-1) and the Department of Health, United
Kingdom. U. S. was supported by Medical Research Council studentship grant
G0500539.
Disclosure of potential conflict of interest: M. Wjst receives research support from the
Helmholtz Center and EU Project European. T. Rochat receives research support from
the Swiss National Foundation for Scientific Research. The rest of the authors have declared that they have no conflict of interest.
Received for publication February 25, 2011; revised August 22, 2011; accepted for publication August 29, 2011.
Corresponding author: Deborah L. Jarvis, MD, Emmanuel Kaye Building, National
Heart and Lung Institute, Imperial College London, Manressa Rd, London SW3
6LR, United Kingdom. E-mail: d.jarvis@imperial.ac.uk.
0091-6749/$36.00
2011 American Academy of Allergy, Asthma & Immunology
doi:10.1016/j.jaci.2011.08.030
996
Key words: Hay fever, IgE sensitization to grass, hygiene hypothesis, older siblings, gene-environment interaction, genome-wide
association study, European Community Respiratory Health Survey,
British 1958 Birth Cohort, Northern Finland Birth Cohort of 1966,
Swiss Study on Air Pollution and Lung Disease in Adults
RAMASAMY ET AL 997
Abbreviations used
AR: Allergic rhinitis
B58C: British 1958 Birth Cohort
ECRHS: European Community Respiratory Health Survey
GWAS: Genome-wide association study
NFBC1966: Northern Finland Birth Cohort of 1966
NOD1: Nucleotide-binding oligomerization domain containing 1
SAPALDIA: Swiss Study on Air Pollution and Lung Disease in
Adults
SLC25A46: Solute carrier family 25 member 46
SNP: Single nucleotide polymorphism
STAT6: Signal transducer and activator of transcription 6
TLR6: Toll-like receptor 6
TMEM232: Transmembrane protein 232
TSLP: Thymic stromal lymphopoietin
METHODS
Participants and studies
This analysis uses information collected from population samples of white
adults taking part in 4 large epidemiologic projects: the British 1958 Birth
Cohort (B58C)10,13; the follow-up of the European Community Respiratory
Health Survey (ECRHS2)14-16; the Northern Finland Birth Cohort of 1966
(NFBC1966)17; and the Swiss Study on Air Pollution and Lung Disease in
Adults (SAPALDIA).18,19 Participants provided information on AR, either underwent skin prick testing or had specific IgE levels to grass measured in serum, and provided blood samples suitable for DNA extraction. Informed
consent was obtained from participants and described elsewhere. Phenotype
definition and study descriptors are provided in Table I.
998 RAMASAMY ET AL
Candidate genes
We searched the HuGE Literature Finder21 for candidate genes using the
following key words: allergic rhinitis or rhinitis or hay fever or grass
pollen; specific and skin prick test; specific and IgE; or hygiene
hypothesis. Then we identified the SNP variants within 5 kb of the flanking
regions of each identified autosomal gene using BioMart.22 Associations of
the phenotypes with these SNPs reaching a P value < 1024 were examined
in detail.
RESULTS
Combining subjects with genome-wide data from the 4
studies, there were 3,933 cases of AR and 8,965 control
subjects. Similarly, there were 2,315 subjects with IgE to grass
sensitization and 10,032 control subjects. Table I shows the
numbers of subjects and the case definitions used in each of
the 4 studies.
TABLE I. Phenotype definition for each study, numbers of cases and control subjects available, and size of the protective effect of hay fever
Study
Location
Age at which
information
was collected
B58C
Britain
(11 regions)
42 for AR
44.5 for IgE
ECRHS2
Europe
(15 centers)
27-57
NFBC1966
Northern
Finland
(5 centers)
31
SAPALDIA
Switzerland
(8 centers)
18-60
Total
Genotyping platform*
AR definition
Affymetrix 500k
(WTCCC)
Illumina 550k (T1DGC)
Illumina Quad 610
(GABRIEL)
No.
of AR
cases
No.
of AR
control
subjects
Unadjusted OR
for AR with
presence of
_1 older sibling
>
1,091
3,699
0.667 (0.581-0.765)
722
1,412
0.885 (0.732-1.069)
1,788
2,912
0.875 (0.771-0.992)
332
942
0.776 (0.600-1.000)
3,933
8,965
0.792 (0.731-0.857)
IgE to grass
definition
No. with
IgE grass
sensitization
No. without
IgE grass
sensitization
HYTEC automated
enzyme immunoassay
to mixed grasses with
0.30 kU/L cutoff
(specific IgE was tested
only if total IgE was
>30 kU/L)
Specific IgE for Timothy
grass using Pharmacia
CAP system with
0.35 kU/L cutoff
Skin prick test for
Timothy grass;
response positive if
MWD grass2MWD
_3 mm
negative control >
927
3,616
465
1,688
695
3,727
228
1001
2,315
10,032
RAMASAMY ET AL 999
AR
Band
Genes
Best SNP
Chromosome
(position)
Risk allele/
reference
1000 RAMASAMY ET AL
TABLE II. List of loci that either achieve genome-wide significance in the meta-analyses of 4 cohorts, have a suggestive association, or are located in candidate genes with 5 3
1026 < P < 1 3 1024 for either phenotype
Grass sensitization
Risk allele
frequency
OR (95% CI)
P value
OR (95% CI)
P value
C/T
T/G
G/C
13.2%
47.0%
8.6%
1.11 (1.03-1.20)
1.17 (1.11-1.24)
1.28 (1.16-1.41)
8.0 3 1023
3.8 3 1028
7.4 3 1027
1.33 (1.21-1.45)
1.22 (1.14-1.31)
1.39 (1.24-1.56)
1.6 3 1029
9.4 3 1029
1.2 3 1028
A/G
G/A
A/G
C/T
A/C
A/G
C/T
T/C
51.3%
21.8%
63.3%
30.3%
14.5%
59.5%
44.7%
7.2%
1.15
1.23
1.16
1.07
1.21
1.09
1.14
1.09
(1.09-1.21)
(1.13-1.34)
(1.09-1.23)
(1.01-1.14)
(1.12-1.31)
(1.03-1.15)
(1.08-1.21)
(0.98-1.22)
9.7
1.0
1.1
1.5
1.9
2.1
2.2
1.1
3
3
3
3
3
3
3
3
1027
1026
1026
1022
1026
1023
1026
1021
1.04
1.09
1.03
1.19
1.09
1.18
1.03
1.35
(0.98-1.12)
(0.98-1.21)
(0.96-1.11)
(1.11-1.28)
(0.99-1.20)
(1.10-1.26)
(0.96-1.10)
(1.19-1.52)
2.0
1.0
3.4
1.1
8.6
2.0
3.9
2.2
3
3
3
3
3
3
3
3
1021
1021
1021
1026
1022
1026
1021
1026
C/T
G/A
C/A
A/G
84.2%
58.5%
28.7%
59.3%
1.07
1.03
1.24
1.01
(0.99-1.17)
(0.98-1.09)
(1.13-1.36)
(0.95-1.06)
9.1
2.6
3.9
8.1
3
3
3
3
1022
1021
1026
1021
1.29
1.18
1.11
1.17
(1.16-1.43)
(1.10-1.26)
(0.99-1.24)
(1.10-1.26)
3.3
3.3
6.2
4.6
3
3
3
3
1026
1026
1022
1026
28
Genome-wide significant loci (SNPs with P < 5 3 10 for either AR or grass sensitization) from GWASs
6p21.32
HLA region
rs7775228
6 (32,766,057)
11q13.5
C11orf30 or LRRC32
rs2155219
11 (75,976,842)
5q22.1
TMEM232 and SLCA25A46
rs17513503
5 (110,174,345)
Suggestive loci (SNPs with 5 3 1028 < P < 5 3 1026 for either AR or grass sensitization) from GWASs
20p11.21 ENTPD6 (previously known as IL-6 signal transducer)
rs1044573
20 (25,154,654)
5q23.1
70 kb to SEMA6A
rs6898653
5 (116,003,555)
16p13.13 C-type lectin domain family 16, member A (CLEC16A)
rs887864
16 (11,066,386)
4q27
IL2
rs2069772
4 (123,730,738)
14q23.1
Near PPM1A and DHRS7 (a dehydrogenase/reductase)
rs216518
14 (59,753,183)
16p13.2
Intergenic region
rs631208
16 (9,307,225)
7p14.1
GLI family zinc finger 3 (GLI3)
rs4724100
7 (42,037,919)
1p32.3
Epidermal growth factor receptor pathway substrate 15
rs6673480
1 (51,571,263)
(EPS15)
5p15.2
DNAH5 (a force generating of respiratory cilia)
rs6554809
5 (13,793,976)
3q22.1
30 kb to transmembrane protein 108 (TMEM108)
rs7617456
3 (134,210,601)
1p36.13
7 kb to ciliary rootlet coiled-coil, rootletin (CROCC)
rs6586513
1 (16,961,637)
1q25.2
v-abl Abelson murine leukemia viral oncogene homolog 2 rs1325195
1 (175,803,413)
(ABL2)
Additional candidate loci not included above (SNPS with 5 3 1026 < P < 1 3 1024 for either AR or grass
5q22.1
TSLP
rs1898671
5 (110,435,901)
4p14
TLR6
rs3860069
4 (38,684,687)
7p14.3
NOD1, previously known as CARD4
rs7789045
7 (30,267,262)
sensitization)
T/C
34.7%
A/C
79.8%
T/A
54.7%
1.15 (1.08-1.22)
1.15 (1.07-1.24)
1.04 (0.98-1.10)
5.2 3 1026
2.7 3 1024
1.5 3 1021
1.10 (1.02-1.18)
1.21 (1.11-1.33)
1.15 (1.08-1.24)
9.0 3 1023
4.4 3 1025
6.2 3 1025
Genes in the HLA region and IL2 are also candidate genes. Positions of SNPs are reported in National Center for Biotechnology Information build 36 coordinates and aligned to the forward strand. The odds ratios reported are per increase
in the risk allele and adjusted for age (in nonbirth cohorts), sex, and locale.
OR, Odds ratio.
J ALLERGY CLIN IMMUNOL
NOVEMBER 2011
RAMASAMY ET AL 1001
FIG 2. Concordance in statistical significance between AR and grass sensitization for the selected loci. Each
loci is represented by the SNP with the lowest P value. The direction of association is consistent between
these 2 phenotypes for the loci shown here (see Table II).
1002 RAMASAMY ET AL
FIG 3. Regional association and forest plots for rs7775228 in the HLA region.
DISCUSSION
We believe that this is the first genome-wide association
meta-analysis of AR and the largest genome-wide interaction
study yet conducted for any allergic disease. We investigated
the associations of prevalent AR and IgE levels to grass pollens
for more than 2.2 million SNPs in almost 13,000 European
white adults and also identified genes that might explain the
protective effect of increasing birth order on disease. Although
we identified several SNPs strongly associated with AR and
IgE to sensitization to grass, we found no consistent evidence
that any SNPs modify the protective effect of increasing birth
order.
The present study has several strengths. First, it includes
GWAS data from almost 13,000 adults of European origin who
were recruited into population-based studies (2 birth cohorts and
2 respiratory cohorts) and therefore has good statistical power to
detect an association. Second, we investigated the association of
SNPs from candidate genes identified in the literature, complementing the genome-wide analysis. Finally, we adopted a
statistically efficient 2-step approach for testing geneenvironment interactions in the context of meta-analyzing
multiple studies.
It is important to recognize several limitations of the
current study. The participants for B58-GABRIEL, ECRHS2,
and SAPALDIA were selected for genotyping based on an
asthma case-control design. Even though these cohorts are
enriched with asthmatic patients and thus are not strictly
population representative, we observed highly consistent associations for our top hits in all cohorts (see forest plots) and
no significant statistical heterogeneity by asthma status (see
Table E4 in this articles Online Repository at www.
jacionline.org), suggesting that the association seen is not an
artifact of sampling.
There are also several limitations on phenotype definitions.
First, the presence of AR is based on self-report and not on a
physicians diagnosis and includes the whole spectrum of disease
severity and allergy-related comorbidities. However, we note that
similar effect sizes were still seen for the majority of the top hits
presented here when we restricted our study to subjects without
asthma or eczema and also when we used a stricter definition
for control subjects and also for cases (see Table E4).
Second, AR could be triggered by exposure to allergens other
than grass, but grass sensitization is common among those with
RAMASAMY ET AL 1003
FIG 4. Regional association and forest plots for rs2155219, which is near C11orf30 (chromosome 11 open
reading frame 30) and LRRC32 (leucine-rich repeat containing 32).
1004 RAMASAMY ET AL
FIG 5. Regional association and forest plots for rs17513503, which is near SLC25A46 and TMEM232.
of this SNP (or other top hits) was changed when stratifying by
sex or asthma or eczema status (see Table E4). It might be relevant
that rs17513503 very weakly transregulates a transcript of Flotlin
1 (208749_x_at, P 5 7.9 3 1024), an HLA gene of unknown
function.
It is striking that in this statistically powerful meta-analysis,
variants in only 4 of 154 previously identified candidate genes
showed more than a moderate association with either hay fever or
grass pollen sensitization. This contrasts with the situation for
serum total IgE levels, in which strong signals emerge with
biologically plausible candidate genes (FCERIA, IL13, and
STAT6), none of which were represented among our prominent
associations. Even though the coverage of candidate SNPs from
the imputation-based GWAS might be incomplete,35 this is rather
surprising given the number of genes tested. It is also intriguing
that most of the strong associations for one phenotype were not
significant for the other phenotype when the GWASs were based
on essentially the same subjects.
Taken together, these observations suggest on the one hand that
the genetic determination of allergic disease might perhaps be
more complicated than hitherto suspected, with distinct pathways
influencing total IgE levels, circulating specific IgE levels, endorgan sensitivity (as manifest by skin prick test responses), and
Key messages
d
One of the genome-wide significant loci has also been previously associated with atopic dermatitis and eczema.
We found no evidence of genetic modification of the protective effect of having older siblings to AR or grass
sensitization.
REFERENCES
1. Burr ML, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989;64:1452-6.
2. Ninan TK, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ 1992;304:873-5.
3. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 2008;8:169-82.
4. Xu J, Postma DS, Howard TD, Koppelman GH, Zheng SL, Stine OC, et al. Major
genes regulating total serum immunoglobulin E levels in families with asthma. Am
J Hum Genet 2000;67:1163-73.
5. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006;7:95-100.
6. Duetsch G, Illig T, Loesgen S, Rohde K, Klopp N, Herbon N, et al. STAT6 as an
asthma candidate gene: polymorphism-screening, association and haplotype analysis in a Caucasian sib-pair study. Hum Mol Genet 2002;11:613-21.
7. Weidinger S, Gieger C, Rodriguez E, Baurecht H, Mempel M, Klopp N, et al.
Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet 2008;4:e1000166.
8. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A
large-scale, consortium-based genomewide association study of asthma. N Engl
J Med 2010;363:1211-21.
9. Wan YI, Strachan DP, Evans DM, Henderson J, McKeever T, Holloway JW, et al.
A genome-wide association study to identify genetic determinants of atopy in subjects from the United Kingdom. J Allergy Clin Immunol 2011;127:223-31, e1-3.
10. Strachan D. Hay fever, hygiene, and household size. BMJ 1989;299:
1259-60.
11. Strachan DP. Family size, infection and atopy: the first decade of the hygiene hypothesis. Thorax 2000;55(suppl 1):S2-10.
12. Karmaus W, Botezan C. Does a higher number of siblings protect against the development of allergy and asthma? A review. J Epidemiol Community Health 2002;
56:209-17.
RAMASAMY ET AL 1005
13. Strachan DP, Rudnicka AR, Power C, Shepherd P, Fuller E, Davis A, et al. Lifecourse influences on health among British adults: effects of region of residence
in childhood and adulthood. Int J Epidemiol 2007;36:522-31.
14. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994;7:954-60.
15. Jarvis D, Chinn S, Luczynska C, Burney P. The association of family size with atopy and atopic disease. Clin Exp Allergy 1997;27:240-5.
16. Genes for asthma? An analysis of the European Community Respiratory Health
Survey. Am J Respir Crit Care Med 1997;156:1773-80.
17. Rantakallio P. Groups at risk in low birth weight infants and perinatal mortality.
Acta Paediatr Scand 1969;193(suppl 193):11.
18. Downs SH, Schindler C, Liu LJ, Keidel D, Bayer-Oglesby L, Brutsche MH, et al.
Reduced exposure to PM10 and attenuated age-related decline in lung function. N
Engl J Med 2007;357:2338-47.
19. Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, Schindler C,
Felber Dietrich D, Stutz EZ, et al. Follow-up of the Swiss Cohort Study on
Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991-2003: methods
and characterization of participants. Soz Praventivmed 2005;50:245-63.
20. R Development Core Team (2008). R: A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN
3-900051-07-0. Available at: http://www.R-project.org. Accessed September 29, 2011.
21. HuGE Literature Finder. HuGE navigator. Available at: http://www.hugenavigator.
net/HuGENavigator/startPagePubLit.do. Accessed September 9, 2010.
22. Haider S, Ballester B, Smedley D, Zhang J, Rice P, Kasprzyk A. BioMart Central
Portalunified access to biological data. Nucleic Acids Res 2009;37(Web Server
issue):W23-7.
23. Murcray CE, Lewinger JP, Gauderman WJ. Gene-environment interaction in
genome-wide association studies. Am J Epidemiol 2009;169:219-26.
24. Ege MJ, Strachan D, Cookson W, Moffatt M, Gut I, Lathrop M, et al. Gene-environment interaction for childhood asthma and exposure to farming in Central Europe. J Allergy Clin Immunol 2011;127:138-44.
25. Esparza-Gordillo J, Weidinger S, Folster-Holst R, Bauerfeind A, Ruschendorf F,
Patone G, et al. A common variant on chromosome 11q13 is associated with atopic
dermatitis. Nat Genet 2009;41:596-601.
26. ORegan G, Campbell L, Cordell H, Irvine A, McLean W, Brown S. Chromosome
11q13.5 variant associated with childhood eczema: an effect supplementary to filaggrin mutations. J Allergy Clin Immunol 2010;125:170-4, e1-2.
27. Marenholz I, Bauerfeind A, Esparza-Gordillo J, Kerscher T, Granell R, Nickel R,
et al. The eczema risk variant on chromosome 11q13 (rs7927894) in the
population-based ALSPAC cohort: a novel susceptibility factor for asthma and
hay fever. Hum Mol Genet 2011;20:2443-9.
28. Fang C, Siew LQ, Corrigan CJ, Ying S. The role of thymic stromal lymphopoietin
in allergic inflammation and chronic obstructive pulmonary disease. Arch Immunol
Ther Exp (Warsz) 2010;58:81-90.
29. Weinmayr G, Genuneit J, Nagel G, Bjorksten B, van Hage M, Priftanji A, et al.
International variations in associations of allergic markers and diseases in children:
ISAAC Phase Two. Allergy 2010;65:766-75.
30. Levine BB, Stember RH, Fotino M. Ragweed hay fever: genetic control and linkage to HL-A haplotypes. Science 1972;178:1201-3.
31. Dixon A, Liang L, Moffatt M, Chen W, Heath S, Wong K, et al. A genome-wide
association study of global gene expression. Nat Genet 2007;39:1202-7.
32. Genome-wide evaluation of validity and efficiency of genotype imputation
[database on the Internet]. Available at: http://www.sph.umich.edu/csg/liang/
imputation/. Accessed September 9, 2010.
33. Koivikko A, Kupias R, Makinen Y, Pohjola A. Pollen seasons: forecasts of the most
important allergenic plants in Finland. Allergy 1986;41:233-42.
34. Hunninghake GM, Soto-Quiros ME, Avila L, Kim HP, Lasky-Su J, Rafaels N, et al.
TSLP polymorphisms are associated with asthma in a sex-specific fashion. Allergy
2010;65:1566-75.
35. Michel S, Liang L, Depner M, Klopp N, Ruether A, Kumar A, et al. Unifying candidate gene and GWAS approaches in asthma. PLoS One 2010;5:e13894.
36. Cramer C, Link E, Horster M, Koletzko S, Bauer CP, Berdel D, et al. Elder siblings
enhance the effect of filaggrin mutations on childhood eczema: results from the 2
birth cohort studies LISAplus and GINIplus. J Allergy Clin Immunol 2010;125:
1254-60, e5.